Misperceived pre-pregnancy weight is associated with excessive gestational weight gain in normal and overweight women, raising the possibility that correcting these misperceptions might lead to healthier pregnancies.

Pregnant women screened for non-RhesusD red blood cell antibodies, particularly those who screen positive, desire more supportive information, but despite some anxiety are generally highly acceptant of the procedure independent of test results or background characteristics.

Misoprostol, a synthetic drug similar to prostaglandin E1, shows promise for reduction of postpartum blood loss when administered in addition to standard oxytocics, suggesting that it may play an important role in treating this life-threatening obstetric complication.